Safety and tolerability of a single dose T0001 in Chinese healthy adult volunteers: a first-in-human ascending dose study-Reference-Cited by-全球学者库

Safety and tolerability of a single dose T0001 in Chinese healthy adult volunteers: a first-in-human ascending dose study

Published:2020 Issue: Volume:56 Page:
ISSN:2175-9790
Container-title:Brazilian Journal of Pharmaceutical Sciences
language:
Short-container-title:Braz. J. Pharm. Sci.

Author:

Zhang Tan¹,Zhang Minjie²,Zu Li’an³,Wang Qian³,Wang Qi¹,Wang Wei⁴,Wang Yitong¹,Zang Yannan⁵,Xie Zhenwei³,Chen Shi³,Wang Mei³,Zheng Qingshan⁶,Li Zhanguo³,Chen Guihong⁷,Fang Yi³^ORCID

Affiliation:

1. Peking University People’s Hospital, China; Peking University Health Science Centre, China

2. Peking University People’s Hospital, China; Xuzhou Medical College, China

3. Peking University People’s Hospital, China

4. Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co. Ltd, China

5. Beijing Key Laboratory of Mental Disorders, China

6. The Center for Drug Clinical Research of Shanghai University of TCM, China

7. Shenzhen Bao’an District Songgang People’s Hospital, China

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/pdf/bjps/v56/2175-9790-bjps-56-e18447.pdf

Reference26 articles.

1. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety;Alonso-Ruiz A;BMC Musculoskel Dis.,2008

2. Leukopenia and thrombocytopenia induced by etanercept: two case reports and literature review;Azevedo VF;Rev Bras Reumatol.,2012

3. The tumor necrosis factor ligand and receptor families;Bazzoni F;New Engl J Med.,1996

4. non-malignant haematological complications of anti-tumour necrosis factor alpha therapy;Bessissow T;Aliment Pharm Therap.,2012

5. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies;Ding T;Rheumatology,2010